DK1636344T3 - Farmaceutisk kompatibel fremgangsmåde til oprensning af intakte bakterielle miniceller - Google Patents

Farmaceutisk kompatibel fremgangsmåde til oprensning af intakte bakterielle miniceller

Info

Publication number
DK1636344T3
DK1636344T3 DK04743793.4T DK04743793T DK1636344T3 DK 1636344 T3 DK1636344 T3 DK 1636344T3 DK 04743793 T DK04743793 T DK 04743793T DK 1636344 T3 DK1636344 T3 DK 1636344T3
Authority
DK
Denmark
Prior art keywords
minicells
provides
purifying
minicell preparations
purified minicell
Prior art date
Application number
DK04743793.4T
Other languages
English (en)
Inventor
Himanshu Brahmbhatt
Jennifer Macdiarmid
Original Assignee
Engeneic Molecular Delivery Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Engeneic Molecular Delivery Pty Ltd filed Critical Engeneic Molecular Delivery Pty Ltd
Application granted granted Critical
Publication of DK1636344T3 publication Critical patent/DK1636344T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK04743793.4T 2003-06-24 2004-06-23 Farmaceutisk kompatibel fremgangsmåde til oprensning af intakte bakterielle miniceller DK1636344T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/602,021 US7611885B2 (en) 2003-06-24 2003-06-24 Pharmaceutically compatible method for purifying intact bacterial minicells
PCT/IB2004/002091 WO2004113507A1 (en) 2003-06-24 2004-06-23 Pharmaceutically compatible method for purifying intact bacterial minicells

Publications (1)

Publication Number Publication Date
DK1636344T3 true DK1636344T3 (da) 2010-05-31

Family

ID=33539477

Family Applications (3)

Application Number Title Priority Date Filing Date
DK10180971.3T DK2333044T3 (da) 2003-06-24 2004-06-23 Farmaceutisk kompatibel fremgangsmåde til oprensning af intakte bakterielle miniceller
DK08101712.1T DK1947171T3 (da) 2003-06-24 2004-06-23 Oprensede bakterieminiceller
DK04743793.4T DK1636344T3 (da) 2003-06-24 2004-06-23 Farmaceutisk kompatibel fremgangsmåde til oprensning af intakte bakterielle miniceller

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK10180971.3T DK2333044T3 (da) 2003-06-24 2004-06-23 Farmaceutisk kompatibel fremgangsmåde til oprensning af intakte bakterielle miniceller
DK08101712.1T DK1947171T3 (da) 2003-06-24 2004-06-23 Oprensede bakterieminiceller

Country Status (19)

Country Link
US (4) US7611885B2 (da)
EP (3) EP2333044B1 (da)
JP (1) JP4834544B2 (da)
CN (2) CN1809629B (da)
AT (2) ATE461269T1 (da)
AU (2) AU2004249970B2 (da)
CA (2) CA2780843C (da)
CY (1) CY1118218T1 (da)
DE (1) DE602004026051D1 (da)
DK (3) DK2333044T3 (da)
ES (3) ES2602572T3 (da)
HK (3) HK1089207A1 (da)
HU (1) HUE030642T2 (da)
MX (1) MXPA05013620A (da)
NZ (1) NZ544653A (da)
PL (2) PL1947171T3 (da)
PT (2) PT1947171E (da)
SI (1) SI2333044T1 (da)
WO (1) WO2004113507A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2302063T (pt) * 2001-10-15 2016-07-28 Engeneic Molecular Delivery Pty Ltd Minicélulas intactas, como vetores para a transferência de adn e terapêutica genética in vitro e in vivo
US7611885B2 (en) 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
NZ547983A (en) 2003-12-09 2009-05-31 Engeneic Molecular Delivery Pty Ltd Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
SI1718338T1 (sl) 2004-02-02 2015-09-30 Engeneic Molecular Delivery Pty Ltd. Sestavki in metode za ciljno usmerjeno in vitro in in vivo dostavo zdravila v celice sesalcev preko bakterijsko pridobljenih intaktnih minicelic
US8772013B2 (en) * 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
AU2005276145C1 (en) 2004-08-26 2011-01-06 Engeneic Molecular Delivery Pty Ltd Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
LT2712618T (lt) 2006-06-23 2017-02-27 Engeneic Molecular Delivery Pty Ltd. Vaistų, terapinių nukleorūgščių ir funkcinių nukleorūgščių tikslinis įvedimas į žinduolio ląsteles per nepažeistas žuvusias bakterines ląsteles
CN101715489B (zh) 2007-03-30 2016-05-25 因詹尼克分子递送控股有限公司 用于体内递送至哺乳动物细胞的、包含无质粒的功能性核酸的、源自细菌的完整小细胞
EP2310502B1 (en) 2008-06-25 2016-02-10 Vaxiion Therapeutics, LLC Regulated genetic suicide mechanism compositions and methods
EP2454276A4 (en) 2008-07-17 2013-07-10 Inter K Pty Ltd THERAPEUTIC AGENTS
CA2760203C (en) * 2009-05-07 2018-10-23 Biomerieux, Inc. Methods for antimicrobial resistance determination
US20120142089A1 (en) * 2010-12-01 2012-06-07 Samsung Electronics Co., Ltd. Method of separating target cell in biological sample
US9624474B2 (en) * 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
US9844598B2 (en) 2011-12-13 2017-12-19 Engeneic Molecular Delivery Pty Ltd Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
WO2013110120A1 (en) 2012-01-24 2013-08-01 Inter-K Pty Limited Peptide agents for cancer therapy
MX2016004285A (es) 2013-10-04 2016-07-08 Engeneic Molecular Delivery Pty Ltd Tratamiento de tumor por combinacion con minicelulas dirigidas a ligando, biespecificas, cargadas con farmacos e interferon-gamma.
SG11201702627UA (en) 2014-10-03 2017-04-27 Engeneic Molecular Delivery Pty Ltd Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
JP6824960B2 (ja) 2015-08-04 2021-02-03 バキシオン セラピューティクス，リミテッド ライアビリティ カンパニー 細菌由来ミニ細胞型バイオ医薬品の電離放射線照射滅菌およびその使用方法
SG11201902940RA (en) 2016-10-06 2019-05-30 Engeneic Molecular Delivery Pty Ltd Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same
JP2021532106A (ja) 2018-07-23 2021-11-25 エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド 細菌由来ミニ細胞を含む組成物およびそれを使用する方法
WO2021257788A1 (en) * 2020-06-17 2021-12-23 Flagship Pioneering Innovations Vi, Llc Methods for manufacturing adas
CN113186100B (zh) * 2021-05-11 2022-10-04 中国科学院青岛生物能源与过程研究所 一种富集污水微生物以用于单细胞精度表型测量和分选的试剂盒及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311797A (en) 1979-09-18 1982-01-19 University Of Saskatchewan Anucleated live E. coli vaccine
IL145778A0 (en) 1999-04-21 2002-07-25 American Home Prod Methods and compositions for inhibiting the function of polynucleotide sequences
US6635448B2 (en) * 2000-08-21 2003-10-21 Clonexdevelopment, Inc. Methods and compositions for increasing protein yield from a cell culture
US7125679B2 (en) * 2001-03-07 2006-10-24 Children's Medical Center Corporation Methods to screen peptide libraries using minicell display
US7011946B2 (en) * 2001-05-22 2006-03-14 Trustees Of Tufts College In vivo assay for identification of antimicrobial agents
US20030194798A1 (en) 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
PT2302063T (pt) 2001-10-15 2016-07-28 Engeneic Molecular Delivery Pty Ltd Minicélulas intactas, como vetores para a transferência de adn e terapêutica genética in vitro e in vivo
EP1487965A4 (en) 2002-02-25 2006-11-15 Mpex Pharmaceuticals Inc MINI COMPOSITIONS AND METHODS
US7611885B2 (en) 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
NZ547983A (en) 2003-12-09 2009-05-31 Engeneic Molecular Delivery Pty Ltd Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
US8772013B2 (en) 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
AU2005276145C1 (en) 2004-08-26 2011-01-06 Engeneic Molecular Delivery Pty Ltd Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
EP2270136A1 (en) 2004-12-17 2011-01-05 Beth Israel Deaconess Medical Center Compositions for bacterial mediated gene silencing and methods of using same
LT2712618T (lt) 2006-06-23 2017-02-27 Engeneic Molecular Delivery Pty Ltd. Vaistų, terapinių nukleorūgščių ir funkcinių nukleorūgščių tikslinis įvedimas į žinduolio ląsteles per nepažeistas žuvusias bakterines ląsteles

Also Published As

Publication number Publication date
AU2009239519B2 (en) 2010-04-22
US8449877B2 (en) 2013-05-28
EP2333044B1 (en) 2016-08-17
EP2333044A1 (en) 2011-06-15
US20040265994A1 (en) 2004-12-30
DE602004026051D1 (de) 2010-04-29
US8003091B2 (en) 2011-08-23
CA2530055C (en) 2012-10-02
AU2004249970A1 (en) 2004-12-29
ES2342830T3 (es) 2010-07-15
DK1947171T3 (da) 2011-09-19
CA2780843C (en) 2013-12-10
CN103361286B (zh) 2016-12-28
CN1809629B (zh) 2013-06-12
EP1947171B1 (en) 2011-06-15
ATE513032T1 (de) 2011-07-15
WO2004113507A9 (en) 2006-08-24
EP1636344A1 (en) 2006-03-22
HUE030642T2 (en) 2017-06-28
CA2530055A1 (en) 2004-12-29
CN103361286A (zh) 2013-10-23
SI2333044T1 (sl) 2016-12-30
NZ544653A (en) 2009-02-28
CA2780843A1 (en) 2012-08-13
MXPA05013620A (es) 2006-02-24
HK1158261A1 (zh) 2012-07-13
AU2004249970B2 (en) 2009-09-10
ES2367535T3 (es) 2011-11-04
US7611885B2 (en) 2009-11-03
CY1118218T1 (el) 2017-06-28
HK1089207A1 (en) 2006-11-24
PL1947171T3 (pl) 2011-12-30
PL2333044T3 (pl) 2017-02-28
ES2602572T3 (es) 2017-02-21
WO2004113507A1 (en) 2004-12-29
US20110177185A1 (en) 2011-07-21
JP2007520201A (ja) 2007-07-26
EP1636344A4 (en) 2006-07-19
US20070241067A1 (en) 2007-10-18
HK1121190A1 (en) 2009-04-17
CN1809629A (zh) 2006-07-26
EP1636344B1 (en) 2010-03-17
US10076545B2 (en) 2018-09-18
DK2333044T3 (da) 2016-12-12
ATE461269T1 (de) 2010-04-15
JP4834544B2 (ja) 2011-12-14
EP1947171A1 (en) 2008-07-23
PT2333044T (pt) 2016-11-21
US20130236422A1 (en) 2013-09-12
PT1947171E (pt) 2011-09-07
AU2009239519A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
CY1118218T1 (el) Φαρμακευτικα συμβατη μεθοδος για τον καθαρισμο αθικτων βακτηριακων μινι-κυτταρων
Gilbert et al. Useful proteins from recombinant bacteria
DE60236145D1 (de) Zellisolierungsverfahren und verwendungen davon
AU6114199A (en) Isolation method for nucleic acid and apparatus
JP2002515508A (ja) 核酸の精製方法および装置
CA2239729A1 (en) Cell separation composition, kit and method
Brown et al. Chloroplast RNA populations in dark-grown, light-grown, and greening Euglena gracilis
HU914094D0 (en) Process for separation of dna
US20050032097A1 (en) Method for processing samples containing sperm and non-sperm cells for subsequent analysis of the sperm DNA
US8088265B2 (en) Cell separation
WO2004048398A1 (ja) 核酸の濃縮精製方法および装置
Krusberg et al. Technique for axenizing nematodes
Allen Isolation of micronuclear and macronuclear DNA
Marin et al. Some evidence for the occurrence of ribonucleic acid in the lutoid fraction (lysosomal compartment) from Hevea brasiliensis latex
Kristiansen et al. Conservation of Active Ribosomes in Acetone‐Treated Cells of Tetrahymena pyriformis
SHIOMI et al. Metrizamide isopycnic centrifugation for the isolation of macro-and micronuclei from Paramecium
AU2004238088B2 (en) Cell separation
Taichman et al. Separation of chromatin containing bromodeoxyuridine in one or both strands of the DNA
Levy-Toledano et al. Human platelet isolation from whole blood on metrizamide gradients
DE69012903D1 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
KR970020168A (ko) 막을 통해 발효 브로쓰로부터 세포를 제거하는 방법
Holmqvist Disappearence of the intracytoplasmic membranes in Rhodopseudomonas sphaeroides: A quantitative ultrastructural study
Sloka Faunistika, dzīvnieku ekoloģija un etoloģija
Takigami et al. 2.9 Removal of Pollutants by Mutant Strains of Microorganisms Induced by Ion-Beam Irradiation Fixation of CO2 by Microalgae
WO2001081616A3 (en) Method for screening of microorganisms under nutrient limited conditions